Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
EHC
|
Greg D Carmichael
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23 Added 0.13% |
-
|
Apr 15
2025 |
|
EHC
|
Leslye G Katz
Director |
BUY
Grant, award, or other acquisition
|
Direct | 76 Added 0.16% |
-
|
Apr 15
2025 |
|
EQH
|
Jeffrey J Hurd
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 6,666 Reduced 6.15% |
$317,101
$47.57 p/Share
|
Apr 15
2025 |
|
EQH
|
Mark Pearson
President and CEO |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 3.88% |
$1,426,800
$47.56 p/Share
|
Apr 15
2025 |
|
EQH
|
Mark Pearson
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 2.52% |
$463,600
$23.18 p/Share
|
Apr 15
2025 |
|
EHC
|
Edward M Christie Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5 Added 0.11% |
-
|
Apr 15
2025 |
|
GH
|
John G. Saia
Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,956 Reduced 8.43% |
$177,426
$44.85 p/Share
|
Apr 15
2025 |
|
GH
|
John G. Saia
Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,568 Added 13.89% |
-
|
Apr 15
2025 |
|
GH
|
Musa Tariq
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 250 Added 6.74% |
-
|
Apr 15
2025 |
|
EHC
|
Terrance Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 23 Added 0.17% |
-
|
Apr 15
2025 |
|
TRC
|
Daniel R Tisch
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,827 Added 2.22% |
$28,957
$15.85 p/Share
|
Apr 15
2025 |
|
VRSN
|
Danny R Mc Pherson
EVP - Technology & CSO |
SELL
Payment of exercise price or tax liability
|
Direct | 26 Reduced 0.08% |
$6,505
$250.23 p/Share
|
Apr 15
2025 |
|
EHC
|
Nancy M Schlichting
Director |
BUY
Grant, award, or other acquisition
|
Direct | 33 Added 0.17% |
-
|
Apr 15
2025 |
|
SNX
|
Ann F Vezina
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 22.8% |
-
|
Apr 15
2025 |
|
KINS
|
Victor J Brodsky
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 15,000 Added 20.12% |
-
|
Apr 15
2025 |
|
CNC
|
Tanya M Mcnally
Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 964 Reduced 1.59% |
$60,741
$63.01 p/Share
|
Apr 15
2025 |
|
GH
|
Myrtle S Potter
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 68 Added 0.48% |
-
|
Apr 15
2025 |
|
CMA
|
Megan D. Crespi
SEVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 399 Reduced 0.85% |
$21,143
$52.99 p/Share
|
Apr 15
2025 |
|
DT
|
Daniel S. Yates
SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 393 Reduced 0.77% |
$17,083
$43.47 p/Share
|
Apr 15
2025 |
|
SELB
|
Emily English
Chief Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,500 Added 13.58% |
$24,750
$3.3 p/Share
|
Apr 15
2025 |
|
SNX
|
Merline Saintil
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 20.98% |
-
|
Apr 15
2025 |
|
VRSK
|
Elizabeth Mann
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 300 Reduced 1.77% |
$88,614
$295.38 p/Share
|
Apr 15
2025 |
|
PAYX
|
Beaumont Vance
Sr VP Data, Analytics, and AI |
SELL
Payment of exercise price or tax liability
|
Direct | 169 Reduced 5.35% |
$24,947
$147.62 p/Share
|
Apr 15
2025 |
|
PAYX
|
Mason Argiropoulos
VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 79 Reduced 3.63% |
$11,661
$147.62 p/Share
|
Apr 15
2025 |
|
CXM
|
Marlise Ricci
Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,980 Added 1.99% |
-
|
Apr 15
2025 |
|
PAYX
|
Joseph M Velli |
BUY
Exercise of conversion of derivative security
|
Direct | 11,489 Added 12.28% |
$544,923
$47.43 p/Share
|
Apr 15
2025 |
|
PAYX
|
Joseph M Velli |
SELL
Open market or private sale
|
Direct | 3,650 Reduced 4.45% |
$544,762
$149.25 p/Share
|
Apr 15
2025 |
|
RYTM
|
Yann Mazabraud
EVP, Head of International |
BUY
Exercise of conversion of derivative security
|
Direct | 11,405 Added 20.44% |
-
|
Apr 15
2025 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,437 Added 4.7% |
$53,233
$8.27 p/Share
|
Apr 15
2025 |
|
HIMS
|
Oluyemi Okupe
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 11,581 Reduced 8.87% |
$330,058
$28.5 p/Share
|
Apr 15
2025 |
|
SNX
|
Nayaki R Nayyar
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 17.1% |
-
|
Apr 15
2025 |
|
MCO
|
Robert Fauber
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 281 Added 0.44% |
$27,006
$96.11 p/Share
|
Apr 15
2025 |
|
MCO
|
Robert Fauber
President and CEO |
SELL
Open market or private sale
|
Direct | 415 Reduced 0.66% |
$181,687
$437.8 p/Share
|
Apr 15
2025 |
|
SNX
|
Claude J Pumilia
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 31.02% |
-
|
Apr 15
2025 |
|
DOCU
|
Blake Jeffrey Grayson
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 8.5% |
$609,200
$76.15 p/Share
|
Apr 15
2025 |
|
SNX
|
Richard T Hume
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 2.93% |
-
|
Apr 15
2025 |
|
CYTK
|
John T Henderson
Director |
SELL
Open market or private sale
|
Direct | 3,190 Reduced 4.59% |
$123,325
$38.66 p/Share
|
Apr 15
2025 |
|
CYTK
|
John T Henderson
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 22.34% |
$124,200
$6.21 p/Share
|
Apr 15
2025 |
|
LNT
|
Antonio P Smyth
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 9,727 Added 50.0% |
-
|
Apr 15
2025 |
|
SHIM
|
Mitchell B. Goldsteen |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$2,980
$1.49 p/Share
|
Apr 15
2025 |
|
MS
|
Eric F Grossman
Chief Legal/Admin Officer |
SELL
Open market or private sale
|
Direct | 10,068 Reduced 4.81% |
$1,124,092
$111.65 p/Share
|
Apr 15
2025 |
|
SNX
|
Kenneth T Lamneck
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 50.0% |
-
|
Apr 15
2025 |
|
LEG
|
Jai Shah
Director |
BUY
Grant, award, or other acquisition
|
Direct | 488 Added 0.86% |
$2,605
$5.34 p/Share
|
Apr 15
2025 |
|
LIDR
|
Andrew S Hughes
Secretary & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 416 Reduced 0.48% |
$274
$0.66 p/Share
|
Apr 15
2025 |
|
SNX
|
Ting Herh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,035 Added 36.12% |
-
|
Apr 15
2025 |
|
MSTR
|
Wei Ming Shao
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 48.55% |
$3,150,000
$315.0 p/Share
|
Apr 15
2025 |
|
MSTR
|
Wei Ming Shao
EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 32.68% |
$175,000
$17.5 p/Share
|
Apr 15
2025 |
|
LEG
|
Phoebe A Wood
Director |
BUY
Grant, award, or other acquisition
|
Direct | 314 Added 0.39% |
$1,676
$5.34 p/Share
|
Apr 15
2025 |
|
ATGE
|
Scott Liles
President, Medical and Vet |
SELL
Payment of exercise price or tax liability
|
Direct | 458 Reduced 5.92% |
$48,712
$106.36 p/Share
|
Apr 15
2025 |
|
AIV
|
Wesley William Powell
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 89,814 Reduced 12.68% |
$691,567
$7.7 p/Share
|
Apr 15
2025 |